Company Profile

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE6483.75241.6 (+3.87 % )
PREV CLOSE (Rs.) 6242.15
OPEN PRICE (Rs.) 6299.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 924
TODAY'S LOW / HIGH (Rs.)6295.00 6515.00
52 WK LOW / HIGH (Rs.)5300 7660
NSE6460.10 206.75 (+3.31 % )
PREV CLOSE(Rs.) 6253.35
OPEN PRICE (Rs.) 6279.00
BID PRICE (QTY) 6460.10 (15 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 20096
TODAY'S LOW / HIGH(Rs.) 6240.00 6496.00
52 WK LOW / HIGH (Rs.)5280 7649.95

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 5.38
TTM EPS (Rs.) 179.85
P/E Ratio 36.05
Book Value (Rs.) 1060.47
Face Value (Rs.) 10
MCap (Rs. in Mn) 149324.80
Price/Earning (TTM) 29.05
Price/Sales (TTM) 4.86
Price/Book (MRQ) 6.11
PAT Margin (%) 13.74
ROCE (%) 28.76
Incorporation Year : 1956

Management Info :

Aditya Narayan - Chairman Rajaram Narayanan - Managing Director

Registered Office :

Address : Sanofi House, 117-b,L&t Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone :

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
25Feb02-25-2020$ Board recommends Final Dividend & One-Time Special Dividend (AGM on April 28, 2020) Board recommends Final Divi
Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2020, inter alia, has considered and approved the following : 1. Recommendation for payment of final dividend of Rs. 106 per equity share Rs. 10 each and one-time special dividend of Rs. 243 per equity share Rs. 10 each for the year ended December 31, 2019. The total dividend recommended is Rs. 349 per equity share Rs. 10 each for the year ended December 31, 2019. 2. The final as well as one-time special dividend, if approved by the shareholders will be paid on or after May 05, 2020.
Sanofi India Ltd has informed BSE that the Board of Directors o..
25Feb02-25-2020$ Corporate Action-Board to consider Dividend Corporate Action-Board to c
We refer to our letter dated 5th February 2020 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 1.30 p.m. and concluded at 4.30 p.m. The following items were considered and approved: 1. Recommendation for payment of final dividend of Rs.106 per equity share Rs. 10 each and one-time special dividend of Rs.243 per equity share Rs. 10 each for the year ended 31st December 2019. The total dividend recommended is Rs. 349 per equity share Rs. 10 each for the year ended 31st December 2019. 2. Convening of the AGM of the Company on Tuesday, 28th April 2020. 3. Closure of Register of Members and Share Transfer Books from 21st April 2020 to 28th April 2020 (both days inclusive) for determining the eligibility of shareholders for payment of final as well as one-time special dividend and Annual General Meeting. 4. The final as well as one-time special dividend, if approved by the shareholders will be paid on or after 5th May 2020.
We refer to our letter dated 5th February 2020 informing you of..
05Feb02-05-2020$Sanofi India informs about board meeting Sanofi India informs about b

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sanofi India has informed that the meeting of the Board of Directors of the Company will be held on 25th February 2020; to approve the audited accounts for the year ended 31st December 2019; and to recommend final dividend for the period mentioned above. 

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 29 of the SEBI (Listing Obligations and..
05Feb02-05-2020$ Board to consider FY19 results & Final Dividend on Feb 25, 2020 Board to consider FY19 resu
Sanofi India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 25, 2020, inter alia, to: 1. Approve the audited accounts for the year ended December 31, 2019. 2. Recommend final dividend for the period mentioned above.
Sanofi India Ltd has informed BSE that the meeting of the Board..
31Jan01-31-2020$Sanofi India informs about loss of share certificate Sanofi India informs about l

Sanofi India has informed  the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed, pursuant to Regulation 39(3) of SEBI (Listing obligations and disclosure requirement) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.

Sanofi India has informed the Company has received communicatio..
Financials More
Rs. in Millions
QTR Dec 19 ANNUAL 19
Net Profit9734142
Gross Profit 1613 5999
Operating Profit 20307594
Net Sales 826330706
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Abbott India (BSE)
 15639.50 (1.19%)
M.Cap ( in Cr)
33232.85
Hester Biosciences (BSE)
 951.70 (2.88%)
M.Cap ( in Cr)
809.60
Procter&Gamble Healt (BSE)
 3669.75 (0.69%)
M.Cap ( in Cr)
6091.56
NGL Fine-Chem (BSE)
 274.45 (8.33%)
M.Cap ( in Cr)
169.56
Suven Pharma (BSE)
 215.50 (6.97%)
M.Cap ( in Cr)
2742.94
Shareholding Pattern More
NON-INSTITUTION 9.96 %
PROMOTERS 60.4 %
FI/BANKS/INSURANCE 2.39 %
MUTUAL FUNDS/UTI 13.86 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes